Flora Growth (FLGC) Competitors $21.26 +1.34 (+6.72%) Closing price 08/22/2025 03:58 PM EasternExtended Trading$21.89 +0.63 (+2.97%) As of 08/22/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. AADI, RENB, HYPD, RNXT, KLTO, EGRX, SNTI, LVTX, COEP, and ACRVShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Aadi Bioscience (AADI), Renovaro (RENB), Hyperion DeFi (HYPD), RenovoRx (RNXT), Klotho Neurosciences (KLTO), Eagle Pharmaceuticals (EGRX), Senti Biosciences (SNTI), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), and Acrivon Therapeutics (ACRV). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Its Competitors Aadi Bioscience Renovaro Hyperion DeFi RenovoRx Klotho Neurosciences Eagle Pharmaceuticals Senti Biosciences LAVA Therapeutics Coeptis Therapeutics Acrivon Therapeutics Flora Growth (NASDAQ:FLGC) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends. Do institutionals and insiders believe in FLGC or AADI? 36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are owned by institutional investors. 12.6% of Flora Growth shares are owned by insiders. Comparatively, 37.3% of Aadi Bioscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, FLGC or AADI? Flora Growth has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Is FLGC or AADI more profitable? Flora Growth has a net margin of -24.86% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-24.86% -261.57% -48.06% Aadi Bioscience -246.06%-71.87%-57.28% Which has preferable valuation & earnings, FLGC or AADI? Flora Growth has higher revenue and earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$59.51M0.21-$15.91M-$34.38-0.62Aadi Bioscience$25.07M1.63-$65.76M-$2.35-0.70 Do analysts prefer FLGC or AADI? Flora Growth presently has a consensus price target of $93.00, indicating a potential upside of 337.46%. Aadi Bioscience has a consensus price target of $1.75, indicating a potential upside of 6.06%. Given Flora Growth's stronger consensus rating and higher possible upside, equities analysts clearly believe Flora Growth is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Aadi Bioscience 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer FLGC or AADI? In the previous week, Flora Growth had 1 more articles in the media than Aadi Bioscience. MarketBeat recorded 1 mentions for Flora Growth and 0 mentions for Aadi Bioscience. Flora Growth's average media sentiment score of 0.91 beat Aadi Bioscience's score of 0.00 indicating that Flora Growth is being referred to more favorably in the media. Company Overall Sentiment Flora Growth Positive Aadi Bioscience Neutral SummaryFlora Growth beats Aadi Bioscience on 11 of the 16 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.53M$10.84B$5.76B$9.61BDividend YieldN/A1.87%4.41%4.10%P/E Ratio-0.6220.9031.1026.04Price / Sales0.2129.65436.34104.14Price / CashN/A24.5537.7358.48Price / Book3.063.519.536.61Net Income-$15.91M$211.77M$3.26B$265.56M7 Day Performance-10.04%4.44%2.10%1.95%1 Month Performance-10.65%8.85%2.81%-0.37%1 Year Performance-47.33%-9.03%30.56%19.02% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth3.308 of 5 stars$21.26+6.7%$93.00+337.5%-44.7%$11.53M$59.51M-0.62280AADIAadi Bioscience0.449 of 5 stars$1.75+1.7%$1.67-4.8%+6.5%$43.22M$25.07M-0.7740RENBRenovaroN/A$0.24-3.4%N/A-63.7%$42.41MN/A-0.3120HYPDHyperion DeFi0.3786 of 5 stars$7.83+5.0%$2.00-74.5%-85.9%$41.80M$60K-0.1340Gap DownRNXTRenovoRx2.8958 of 5 stars$1.12-2.2%$7.25+550.2%-3.1%$41.69M$40K-2.796News CoverageAnalyst UpgradeShort Interest ↓Analyst RevisionKLTOKlotho NeurosciencesN/A$0.83-8.0%N/AN/A$41.64MN/A-2.31N/AEarnings ReportGap UpEGRXEagle Pharmaceuticals1.7681 of 5 stars$3.20+0.3%N/AN/A$41.56M$257.55M0.00100SNTISenti Biosciences2.6108 of 5 stars$1.52-3.8%$8.50+459.2%-38.6%$41.33M$2.56M-0.174LVTXLAVA Therapeutics1.5356 of 5 stars$1.52-0.7%$2.69+76.6%-18.2%$40.25M$11.98M-1.4660Short Interest ↓COEPCoeptis Therapeutics0.7107 of 5 stars$11.06-0.9%N/A+228.9%$39.21MN/A-1.912News CoveragePositive NewsShort Interest ↑ACRVAcrivon Therapeutics2.5878 of 5 stars$1.23-0.8%$17.71+1,340.2%-84.3%$38.88MN/A-0.5558 Related Companies and Tools Related Companies AADI Competitors RENB Competitors HYPD Competitors RNXT Competitors KLTO Competitors EGRX Competitors SNTI Competitors LVTX Competitors COEP Competitors ACRV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access